---
title: "Applied Survival Analysis"
subtitle: "Chapter 3 - Nonparametric Estimation and Testing"
css: style_slides.css
author:
  name: Lu Mao
  affiliation: 
   - name: Department of Biostatistics & Medical Informatics
   - University of Wisconsin-Madison
  email: lmao@biostat.wisc.edu
format: revealjs

      
editor: visual
include-in-header:
  - text: |
      <style type="text/css">
      ul li ul li {
        font-size: 0.75em;
      }
      </style>
---

## Outline

::: incremental
1.  Nelsen--Aalen estimator of cumulative hazard\
2.  Kaplan--Meier estimator of survival function\
3.  Log-rank test and variations\
4.  Analysis of the German Breast Cancer study\
:::

$$\newcommand{\d}{{\rm d}}$$ $$\newcommand{\dd}{{\rm d}}$$ $$\newcommand{\pr}{{\rm pr}}$$ $$\newcommand{\var}{{\rm var}}$$ $$\newcommand{\se}{{\rm se}}$$ $$\newcommand{\indep}{\perp \!\!\! \perp}$$

# Nelsen--Aalen Estimator

## Nonparametric Approach

::: fragment
-   **Motivation**
    -   Naive empirical distribution biased with censoring
    -   Parametric models constrained
        -   Weibull model $\to$ monotone risk
:::

::: fragment
-   **Nonparametric inference**
    -   Estimation of $S(t)=\pr(T >t)$
    -   Comparison of survival function between groups
:::

::: fragment
-   **Discrete hazard**: a useful tool
:::

## Discrete Hazard: Set-up

::: incremental
-   **Observed data** $$(X_i, \delta_i)\,\, (i=1,\ldots, n)$$ ![](images/km_discr_haz.png){fig-align="center" width="65%"}
    -   $0<t_1<\cdots<t_m$: unique observed **event** (failure) times (the $X_i$ with $\delta_i =1$)
    -   $d_j$: number of observed failures at $t_j$
    -   $n_j$: number of subjects at risk $t_j$ (those with $X_i\geq t_j$)
        -   $n_{j-1} - n_j$: number of failures and censorings in $[t_{j-1}, t_j)$
:::

## Discrete Hazard: Definition

::: fragment
-   **Counting process notation** $$d_j = \sum_{i=1}^n \dd N_i(t_j)\, \mbox{ and }\,\, n_j = \sum_{i=1}^n I(X_i \geq t_j)$$
:::

::: fragment
-   **Discretize distribution** at observed event times $$t_1<t_2<\cdots<t_m$$
    -   **Discrete hazard** $$\dd\Lambda(t_j)=\pr(t_j \leq T < t_j+\dd t\mid T\geq t_j)=\pr(T = t_j\mid T\geq t_j)$$
        -   $\dd\Lambda(t)\equiv 0$ otherwise
:::

## Nelsen--Aalen Estimator (I)

::: fragment
-   Recall in Chapter 2...\begin{align}
    E\{\dd N(t)\mid X\geq t\}&=\frac{\pr\{\dd N^*(t)=1, C\geq t\}}{\pr(T\geq t, C\geq t)}
    \notag\\
    &=\frac{\pr\{\dd N^*(t)=1\}\pr(C\geq t)}{\pr(T\geq t)\pr(C\geq t)}
    \notag\\
    &=E\{\dd N^*(t)\mid T\geq t\}\notag\\
    &=\dd\Lambda(t),
    \end{align}

    -   So $$\dd\Lambda(t_j) = E\{\dd N(t_j)\mid X\geq t_j\}=\frac{E\{\dd N(t_j)\}}{\pr(X\geq t_j)}$$
:::

## Nelsen--Aalen Estimator (II)

::: fragment
-   Motivates **empirical estimator** \begin{align}
    \dd\hat\Lambda(t_j) & = \frac{d_j}{n_j} =
    \frac{\sum_{i=1}^n \dd N_i(t_j)}{\sum_{i=1}^n I(X_i\geq t_j)}\\
    &=\mbox{proportion of failures among those at risk}
    \end{align}
:::

::: fragment
-   **Cumulative hazard** $$
    \hat\Lambda(t)=\sum_{j:t_j\leq t}\frac{d_j}{n_j} =\int_0^t\frac{\sum_{i=1}^n \dd N_i(u)}{\sum_{i=1}^n I(X_i\geq u)}
    $$
    -   Nelsen--Aalen estimator
    -   A step function (starting from 0) that jumps $d_j/n_j$ at $t_j$ $(j=1,\ldots, m)$
:::

## Example: Rat Carcinogen Study (I)

::: fragment
-   **Carcinogenicity study**: 100 rats treated with a drug
    -   Followed for tumor development
:::

::: fragment
![](images/km_rats_dat.png){fig-align="center" width="70%"}
:::

## Example: Rat Carcinogen Study (II)

::: fragment
-   **Follow-up plot** (sub-sample)

![](images/km_rats_fu.png){fig-align="center" width="75%"}
:::

## Example: Rat Carcinogen Study (III)

::: fragment
-   **"Hand" calculations**

![](images/km_rats_na.png){fig-align="center" width="70%"}
:::

## Example: Rat Carcinogen Study (IV)

::: fragment
-   **Visualization**

![](images/km_rats_na_plot.png){fig-align="center" width="80%"}
:::

# Kaplan--Meier Estimator

## From Hazard to Survival

::: fragment
-   **Continuous** relationship $$
    \tilde S(t)=\exp\left\{-\hat\Lambda(t)\right\}
    $$
:::

::: fragment
-   **Discrete** relationship (more general and intuitive)

![](images/km_discr_haz.png){fig-align="center" width="65%"}
:::

## Progressive Conditioning

::: fragment
-   **Surviving past** $t_j$: step by step \begin{align*}
    S(t_j)&=\pr(T>t_j)\\
    &=\pr(T>t_1)\pr(T>t_2\mid T>t_1)\cdots\pr(T>t_j\mid T>t_{j-1})\\
    &=\pr(T>t_1\mid T\geq t_1)\pr(T>t_2\mid T\geq t_2)\cdots\pr(T>t_j\mid T\geq t_j)\\
    &=\prod_{l=1}^j\pr(T>t_l\mid T\geq t_l),
    \end{align*}
:::

::: fragment
-   **Overall** \begin{equation*}
    S(t)=\prod_{j:t_j\leq t}\pr(T>t_j\mid T\geq t_j) 
    \end{equation*}
:::

## Kaplan--Meier Estimator

::: fragment
-   **Each conditional survival** $$
    \pr(T>t_j\mid T\geq t_j) = 1-\pr(T=t_j\mid T\geq t_j) = 1-\dd\Lambda(t_j)
    $$
:::

::: fragment
-   **Plug-in Nelsen--Aalen** \begin{equation}
    \hat S(t)=\prod_{j:t_j\leq t}\{1-\dd\hat\Lambda(t_j)\}=\prod_{j:t_j\leq t}(1-d_j/n_j)
    \end{equation}
    -   Kaplan--Meier (product-limit) estimator
    -   Reduces to empirical survival in the absence of censoring
    -   Adjusts for censoring by updating number at risk $t_j$ over time
:::

## Kaplan--Meier Estimator: Variance (I)

::: fragment
-   $\var\{\hat S(t)\}$?
    -   **Log-transform**: product $\to$ sum $$
        \log\hat S(t)=\sum_{j:t_j\leq t}\log(1-d_j/n_j)
        $$

    -   **Delta method**$^*$ $$
        \hat\var\{\hat S(t)\}=\hat S(t)^2\hat\var\{\log\hat S(t)\},
        $$
:::

:::: fragment
::: callout-note
## Delta Method

If approximately $S_n \sim N(\mu, \sigma^2)$, then approximately $g(S_n) \sim N\left\{g(\mu), \dot g(\mu)^2\sigma^2\right\}$, where $\dot g(\mu)=\dd g(\mu)/\dd\mu$.
:::
::::

## Kaplan--Meier Estimator: Variance (II)

::: incremental
-   $\var\{\log\hat S(t)\}$?
    -   With the $n_j$ fixed, the $d_j$ are independent (different subjects) \begin{align}
        \hat{\rm var}\{\log\hat S(t)\}&=\sum_{j:t_j\leq t}\hat{\rm var}\left[\log\{1-d_j/n_j\}\right]\notag\\
        &\approx \sum_{j:t_j\leq t}\frac{n_j^2}{(n_j-d_j)^2}\hat{\rm var}(d_j/n_j)\tag{Delta method}\\
        &=\sum_{j:t_j\leq t}\frac{d_j}{n_j(n_j-d_j)},
        \end{align}
    -   Last equality: variance of binomial proportion $$
        \hat{\rm var}(d_j/n_j)=(d_j/n_j)(1-d_j/n_j)/n_j
        $$
:::

## Kaplan--Meier Estimator: Variance (III)

::: fragment
-   **Variance of KM** \begin{equation}\label{eq:km:greenwood}
    \hat\var\{\hat S(t)\}=\hat S(t)^2\sum_{j:t_j\leq t}\frac{d_j}{n_j(n_j-d_j)}
    \end{equation}

    -   Greenwood's formula
:::

::: fragment
-   **Naive 95% confidence interval** (CI) \begin{equation}\label{eq:km:ci_plain}
    \left[\hat S(t)-1.96\hat\se\{\hat S(t)\}, \hat S(t)+1.96\hat\se\{\hat S(t)\}\right]
    \end{equation} <!-- -   $\hat\se = \hat\var^{1/2}$ -->

    -   May contain values outside $[0, 1]$
    -   Bounded quantity approximated by unbounded (normal) distribution
:::

## Kaplan--Meier Estimator: CI

::: incremental
-   **Log-log transformed CI**
    -   Transform $\zeta(t)=\log\{-\log S(t)\} \in \mathbb R$

    -   CI for $\zeta(t)$ \begin{equation}
        \left[\hat\zeta(t)-1.96\hat\se\{\hat\zeta(t)\},\hat\zeta(t)+1.96\hat\se\{\hat\zeta(t)\}\right]
        \end{equation}

    -   Transform the bounds back to $S(t)$ $$
        \left[\hat S(t)^{\exp[1.96\hat\se\{\hat\zeta(t)\}]}, \hat S(t)^{\exp[-1.96\hat\se\{\hat\zeta(t)\}]}\right]
        \subset [0, 1]
        $$

    -   Remains to calculate $\hat\se\{\hat\zeta(t)\}$ by delta method (Exercise)
:::

## Example: Rat Carcinogen Study (V)

::: fragment
-   **"Hand" calculations**

![](images/km_rats_surv_tab.png){fig-align="center" width="65%"}
:::

## Software: `survival::survfit()` (I)

:::: fragment
-   **Basic syntax** for fitting KM curve

::: big-code
```{r}
#| eval: false
#| echo: true

 # df: data frame; time: X; status: delta
obj <- survfit(Surv(time, status) ~ 1, data = df, 
               conf.type = "log-log")
```
:::
::::

::: incremental
-   **Input**
    -   `Surv(time, status) ~ 1`: fit curve to a homogeneous sample
        -   `Surv(time, status) ~ group`: fit curve to each level of `group`
    -   `data = df`: input data frame `df`
    -   `conf.type = "log-log"`: log-log transformation for CI
        -   `"log"`: default log transformation
        -   `"plain"`: naive CI
:::

## Software: `survival::survfit()` (II)

::: fragment
-   **Output**: a `surfit` object containing KM estimates
    -   Call `summary()` and `plot()`
    -   `summary(obj)`: a list containing
        -   `time`: $t_j$ $(j=1,\ldots, m)$
        -   `surv`: $\hat S(t_j)$
        -   `n.risk`: $n_j$
        -   `n.event`: $d_j$
        -   `std.err`: $\hat\se\{\hat S(t_j)\}$
        -   `...`
:::

## Software: `gtsummary::tbl_survfit()`

::: fragment
-   **Customizable, publication-ready table**
    -   Based on `survfit()` results
:::

::: fragment
```{r}
#| eval: false
#| echo: true
#| code-line-numbers: "1-2|3-4|6-8|9|10-11|13-14"

# install.packages("gtsummary")
library(gtsummary)
# A single-group KM model
obj <- survfit(Surv(time, status) ~ 1, data = df)

# Summaries at specific times
tbl_surv <- tbl_survfit(
  x = obj,                         # Provide the fitted survfit object
  times = seq(40, 100, by = 20),   # Time points for survival rates
  label_header = "{time} days"     # Column label: "xx days"
)

# Print out the table
tbl_surv
```
:::

## Software: `ggsurvfit::ggsurvfit()`

::: fragment
-   **Enhanced KM plot**
    -   Powered by `ggplot2`
:::

::: fragment
```{r}
#| eval: false
#| echo: true
#| code-line-numbers: "1-2|3|5-8|9-15"

# install.packages("ggsurvfit")
library(ggsurvfit)
obj <- survfit(Surv(time, status) ~ 1, data = df)

# Create a KM plot with confidence intervals and an at-risk table
ggsurvfit(obj) +
  add_confidence_interval() + # Shaded 95% CI region
  add_risktable() +           # Show risk table
  scale_x_continuous(breaks = seq(0, 100, by = 20)) + # X-axis breaks
  ylim(0, 1) +                # Y-axis limits
  labs(
    x = "Time (days)",
    y = "Tumor-free probabilities"
  ) +
  theme_minimal()
```
:::

## Example: Rat Carcinogen Study (VI)

::: fragment
-   Data frame: `rats.rx`
    -   Check with Table 3.3
:::

::: fragment
```{r}
#| eval: false
library(survival)
rats <- read.table("Data//Rat Tumorigenicity Study//rats.txt",header=T)

#subset to treatment arm
rats.rx <- rats[rats$rx==1,]
```

```{r}
#| eval: false
#| echo: true
#| code-line-numbers: "1-2|3-13"

obj <- survfit(Surv(time, status) ~ 1, data = rats.rx, 
               conf.type = "log-log")
summary(obj)
# Call: survfit(formula = Surv(time, status) ~ 1, data = rats.rx, 
#               conf.type = "log-log")
# 
# time n.risk n.event survival std.err lower 95% CI upper 95% CI
#   34     99       1    0.990  0.0100        0.930        0.999
#   39     98       1    0.980  0.0141        0.922        0.995
#   45     97       1    0.970  0.0172        0.909        0.990
#   67     89       1    0.959  0.0202        0.894        0.984
#   70     86       1    0.948  0.0228        0.879        0.978
#   ...
```
:::

## Example: Rat Carcinogen Study (VII)

::: fragment
-   Plot the survival function (with 95% CI)
    -   Base `plot()`
:::

::: fragment
```{r}
#| eval: false
#| echo: true
#| code-line-numbers: "1-3|5-6"
# plot the estimated survival function
plot(obj, ylim = c(0,1), xlim = c(0, 100), lwd = 2, frame.plot = FALSE,
     xlab = "Time (days)", ylab = "Tumor-free probabilities", main = "")

legend(1, 0.2, c("Kaplan-Meier curve", "95% Confidence limits"),
       lty = 1:2, lwd = 2)
```
:::

## Example: Rat Carcinogen Study (VIII)

::: fragment
-   Result

![](images/km_rats_surv.png){fig-align="center" width="70%"}
:::

# Log-Rank Test

## Comparing Survival Rates

::: fragment
-   **Motivation**: compare event rate across groups for treatment/exposure effect
:::

::: fragment
-   **Example**
    -   **Rat study**: 100 treated (analyzed) vs 200 untreated for tumor incidence
    -   **GBC study**: hormone vs non-hormone treatments for (relapse-free) survival
:::

::: fragment
-   **Hypothesis** \begin{equation}\label{eq:km:null}
        H_0: S_1(t)=S_0(t) \mbox{ for all } t.
    \end{equation}
    -   $S_a(t) =$ survival function of $T$ in group $a$ ($1$: treatment; $0$: control)
:::

## Two-Group Comparison: Set-up

::: incremental
-   **Observed data** \begin{equation}
    \{(X_{1i},\delta_{1i}): i=1,\ldots, N_1\} \mbox{ and } \{(X_{0i},\delta_{0i}): i=1,\ldots, N_0\},
    \end{equation}
    -   $(X_{ai},\delta_{ai})$ $(i=1,\ldots, N_a)$: a random sample of $(X,\delta)$ in group $a$\
        ![](images/km_discr_logrank.png){fig-align="center" width="80%"}
    -   $n_{1j}$, $n_{0j}$: numbers at risk in groups 1 and 0 at $t_j$ (totaling $n_j = n_{1j} + n_{0j}$ at risk)
    -   $d_{1j}$, $d_{0j}$: numbers of events in groups 1 and 0 at $t_j$ (totaling $d_j = d_{1j} + d_{0j}$ events)
:::

## Two-Group Comparison: Contingency

::: fragment
-   **Fixing** $d_j$ (total \# uninformative of group difference)
:::

::: fragment
![](images/km_logrank_contingency.png){fig-align="center" width="75%"}
:::

## Two-Group Comparison: Log-rank (I)

::: incremental
-   **Contingency table** $(2\times 2)$
    -   $H_0$: No association between **event occurence** vs **group affiliation**
    -   Event occurs in proportion to number at risk \begin{align}
        R_j&=d_{1j}-d_j\frac{n_{1j}}{n_j}\\
        &=\mbox{(Observed events)} - \mbox{(Expected events)}
        \end{align}
    -   $R_j > 0$: higher incidence in treatment; $R_j < 0$: higher incidence in control
    -   $E(R_j\mid d_j, n_{1j}, n_{0j})\stackrel{H_0}{=}0$
    -   $\var(R_j\mid d_j, n_{1j}, n_{0j})\stackrel{H_0}{=:} V_j$ by hypergeometric distribution
:::

## Two-Group Comparison: Log-rank (II)

::: incremental
-   **Testing overall incidence** \begin{equation}\label{eq:km:logrank_stat}
    S_{N_1,N_0}=\frac{(\sum_{j=1}^m R_j)^2}{\sum_{j=1}^m V_j}\stackrel{H_0}{\sim} \chi_1^2
    \end{equation}
    -   $\hat\var(\sum_{j=1}^m R_j)=\sum_{j=1}^m V_j$ by conditioning (martingale) arguments
        -   Uncorrelated increments
    -   Reject $H_0$ if $$S_{N_1,N_0}>\chi_1^2(1-\alpha)$$
        -   $\chi_1^2(1-\alpha)$ is the $100(1-\alpha)$th percentile of $\chi_1^2$
    -   Log-rank test (with significance level $\alpha$)
:::

## Two-Group Comparison: Log-rank (III)

::: incremental
-   **Alternative hypothesis** \begin{equation}\label{eq:km:logrank_alter}
    H_A: \lambda_1(t)\leq\lambda_0(t)\mbox{ for all } t \mbox{ with strict inequality for some }t
    \end{equation}
    -   **Ordered hazards**: treatment **consistently** lowers risk over time compared to control (or *vice versa*) $$\pr\left\{S_{N_1,N_0}>\chi_1^2(1-\alpha)\right\}\stackrel{H_A}{\to} 1 \mbox{ as } n\to\infty$$
    -   $\sum_{j=1}^m R_j =$ Weighted difference of group-specific Nelsen--Aalen estimates of hazard functions (Section 3.2.2)
    -   **Crossing hazards** $\to$ weak power
:::

## Log-Rank Extension: Multiple Groups

::: incremental
-   $K$ groups $(k = 0, 1, \ldots, K-1)$ \begin{equation}\label{eq:km:logrank_mult}
    \gamma=\sum_{j=1}^m\left(d_{1j}-d_j\frac{n_{1j}}{n_j},d_{2j}-d_j\frac{n_{2j}}{n_j},\ldots, d_{K-1,j}-d_j\frac{n_{K-1,j}}{n_j}\right)^{\rm T}
    \end{equation}
    -   $t_1<\cdots<t_m$: unique event times pooled across $K$ groups
    -   $d_{kj}, n_{kj}$: numbers of failed and at-risk subjects in group $k$ at $t_j$
    -   Test statistic $$
        \gamma^{\rm T}\var(\gamma)^{-1}\gamma\stackrel{H_0}{\sim}\chi_{K-1}^2
        $$
    -   **Alternative hypothesis**: exist two groups with ordered hazards
:::

## Log-Rank Extension: Stratification

::: fragment
-   **Stratification**: compare groups only within same stratum
    -   Race/ethnicity, sex, age group, study center
    -   Adjust for confounder
    -   Statistical efficiency
:::

::: fragment
-   **Test statistic**
    -   Calculate and aggregate stratum-specific $\sum_{j=1}^m R_j$
    -   **Alternative hypothesis**: ordered hazards (same order) across strata
:::

## Log-Rank Extension: Weighting (I)

::: incremental
-   **Weight** $w_j$ at time $t_j$: \begin{equation}\label{eq:eq:km:ej_w}
    \frac{(\sum_{j=1}^{m} w_jR_{j})^2}{\sum_{j=1}^{m} w_j^2V_{j}} \stackrel{H_0}{\sim} \chi_1^2
    \end{equation}
    -   Log-rank: $w_j\equiv 1$
    -   Gehan: $w_j = n_j/n$
    -   Harrington-Fleming (HF) $G^\rho$ family: $\hat S(t_j-)^\rho$ $(\rho\geq 0)$
        -   $\hat S(t_j-)$: KM estimate based on pooled sample
        -   Extended to $G^{\rho,\gamma}$ family: $\hat S(t_j-)^\rho\{1-\hat S(t_j-)\}^\gamma$ $(\rho, \gamma \geq 0)$
:::

## Log-Rank Extension: Weighting (II)

::: incremental
-   **Choice**
    -   **Pre-specify** to avoid bias
    -   **Decreasing weights**: sensitive to early effects
    -   **Increasing weights**: sensitive to delayed effects
    -   **Constant weight** (default): optimal for proportional hazards alternative $$
        H_A^{\rm PH}:\lambda_1(t)=\exp(\theta)\lambda_0(t) \mbox{ for all } t
        $$
:::

## Software: `survival::survdiff()`

:::: fragment
-   **Basic syntax** for log-rank test

::: big-code
```{r}
#| eval: false
#| echo: true

# Log-rank test
survdiff(Surv(time, status) ~ group + strata(str_var), rho)
```
:::
::::

::: fragment
-   **Input**
    -   `Surv(time, status) ~ group`: test survival function between levels of variable `group`
    -   `strata(str_var)`: stratified by variable `str_var` (optional)
    -   `rho = r`: weights $\hat S(t_j-)^\rho$ with $\rho=$ `r`
-   **Output**: a list containing `pvalue` (p-value of the test)
:::

## Software: `gtsummary::tbl_survfit()`

::: fragment
-   **Multi-group tabulation**

```{r}
#| eval: false
#| echo: true
#| code-line-numbers: "2-3|10"
library(gtsummary)
# A two-group KM model
obj <- survfit(Surv(time, status) ~ rx, data = rats)

# Summaries at specific times with labeled treatment groups
tbl_surv <- tbl_survfit(
  x = obj,                         # Provide the fitted survfit object
  times = seq(40, 100, by = 20),   # Time points for survival rates
  label_header = "{time} days",    # Column label: "xx days"
  label = list(rx ~ "Treatment")   # Rename 'rx' to 'Treatment'
)

# Print out the table
tbl_surv
```
:::

## Software: `ggsurvfit::ggsurvfit()`

::: fragment
-   **Multi-group KM graphics**

```{r}
#| eval: false
#| echo: true
#| code-line-numbers: "3-4|8-13"
library(ggsurvfit)

# Use survfit2 as recommended by ggsurvfit
obj2 <- survfit2(Surv(time, status) ~ rx, data = rats)

# Create a group-specific KM plot with log-rank test p-value
ggsurvfit(obj, linetype_aes = TRUE, linewidth = 1) +  # Use line types 
  add_risktable(                    
    risktable_stats = "n.risk",  # Include only numbers at risk
    theme = list(
      theme_risktable_default(),  # Default risk table theme
      scale_y_discrete(labels = c('Drug', 'Control'))  # Group labels
    )
  ) +  
  theme_classic() 
```
:::

## Example: Rat Carcinogen Study (IX)

-   Log-rank test by `rx` stratified by `sex`

```{r}
#| eval: false
#| echo: true
#| code-line-numbers: "1-6|8|9-10|12-16"
head(rats)
#   litter rx time status sex
# 1      1  1  101      0   f
# 2      1  0   49      1   f
# 3      1  0  104      0   f
# ...

survdiff(Surv(time, status) ~ rx + strata(sex), data = rats)
# Call:
# survdiff(formula = Surv(time, status) ~ rx + strata(sex), data = rats)
# 
#        N Observed Expected (O-E)^2/E (O-E)^2/V
# rx=0 200       21     28.9      2.16      6.99
# rx=1 100       21     13.1      4.77      6.99
# 
#  Chisq= 7  on 1 degrees of freedom, p= 0.008 
```

# Application: German Breast Cancer Study

## Baseline Characteristics

::: fragment
-   686 patients with primary node positive breast cancer

![](images/km_gbc_tab1.png){fig-align="center" width="70%"}
:::

## Relapse-Free Survival: Overall

::: fragment
-   **Endpoint**: the earlier of relapse or death ![](images/km_gbc_rfs.png){fig-align="center" width="80%"}
:::

## Relapse-Free Survival: Subgroups

::: fragment
-   **Menopausal status**: pre- vs post-menopausal ![](images/km_gbc_rfs_meno.png){fig-align="center" width="80%"}
:::

## Hormone Treatment Effect

::: fragment
-   **Hormonal therapy**
    -   Stratified by menopausal status

```{r}
#| eval: false
#| echo: true

## Stratified log-rank test (by menopausal status)
survdiff(Surv(time, status) ~ hormone + strata(meno),
         data = data.CE)
```
:::

::: incremental
-   **Result**
    -   $\chi_1^2=$ 9.5 with p-value 0.002
        -   Adjusting for menopausal status, hormonal therapy has a highly significant beneficial effect on relapse-free survival in breast cancer patients
    -   Unadjusted test result similar
:::

# Conclusion

## Notes

::: fragment
-   **Kaplan and Meier (1958)**
    -   60k + citations by Feb 2025
    -   Most cited statistical paper of all time
:::

::: fragment
-   **Derivation of log-rank**
    -   Mantel--Haenszel (1959) analysis of $2\times 2$ contingency tables stratified by $t_j$
:::

::: fragment
-   **Other tests**
    -   **Gehan** `npsm::gehan.test()`
    -   **Max-combo** `nph::logrank.maxtest()` (maximum over multiple weighting schemes)
:::

## Summary (I)

::: fragment
-   **Discrete hazard**: $\dd\Lambda(t_j)= d_j/n_j$ ![](images/km_discr_haz.png){fig-align="center" width="50%"}
    -   Proportion of failures among those at risk
:::

::: fragment
-   **Kaplan--Meier** \begin{equation}
    \hat S(t)=\prod_{j:t_j\leq t}\{1-\dd\hat\Lambda(t_j)\}=\prod_{j:t_j\leq t}(1-d_j/n_j)
    \end{equation}
    -   `survival::survfit()`:
:::

## Summary (II)

::: fragment
-   **Log-rank test**: multi-group comparison
    -   $K$ groups $\to$ $K-1$ degrees of freedom
    -   **Stratification**: adjust for confounding
    -   **Weighting**: optimality depends on effect pattern over time
    -   `survival::survdiff()`
:::

::: fragment
-   **Enhanced tabulation and graphics**
    -   `gtsummary::tbl_survfit()`
    -   `ggsurvfit::ggsurvfit()`\
:::

## HW2 (Due Feb 19)

-   Choose one

    -   Problem 3.2
    -   Problem 3.3

-   Problem 3.19

-   (Extra credit) Choose one

    -   Problem 3.15
    -   Problems 3.17 and 3.18
